Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Zezhen Liu"'
Autor:
Jie Zeng, Jiahong Chen, Maozhang Li, Chuanfan Zhong, Zezhen Liu, Yan Wang, Yuejiao Li, Funeng Jiang, Shumin Fang, Weide Zhong
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Metastatic castration-resistant prostate cancer (mCRPC) is a highly aggressive stage of prostate cancer, and non-mutational epigenetic reprogramming plays a critical role in its progression. Super enhancers (SE), epigenetic elements, are
Externí odkaz:
https://doaj.org/article/55a0b7d904284d2baebba47942631f43
Autor:
Jianming Lu, Chuanfan Zhong, Junqi Luo, Fangpeng Shu, Daojun Lv, Zezhen Liu, Xiao Tan, Shuo Wang, Kaihui Wu, Taowei Yang, Weibo Zhong, Bin Wang, Yanfei Chen, Yuehan Li, Zhenyu Jia, Yaguang Zou, Weide Zhong, Xiangming Mao
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 26, Iss , Pp 927-944 (2021)
The circRNAs, a new subclass of non-coding RNAs that are catalyzed by RNA-binding proteins (RBPs), have been reported to be associated with the progression of multiple types of cancer. We previously discovered that heterogeneous nuclear ribonucleopro
Externí odkaz:
https://doaj.org/article/83707a8c1a534f6abab965e93be541bc
Autor:
Chaojiang Chen, Zhiduan Cai, Yangjia Zhuo, Ming Xi, Zhuoyuan Lin, Funeng Jiang, Zezhen Liu, Yueping Wan, Yu Zheng, Jianxin Li, Xing Zhou, Jianguo Zhu, Weide Zhong
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Solute Carrier Family 6 Member 1 (SLC6A1) has been identified as a cancer-promoting gene in various human cancers, such as clear cell renal cell carcinoma and ovarian cancer. However, its roles in prostate cancer (PCa) has not bee
Externí odkaz:
https://doaj.org/article/aa774ee3b07c4a1a81f6b181cb5be70d
Autor:
Zezhen Liu, Jiehui Zhong, Jie Zeng, Xiaolu Duan, Jianming Lu, Xinyuan Sun, Qinwei Liu, Yingke Liang, Zhuoyuan Lin, Weide Zhong, Wenzheng Wu, Chao Cai, Guohua Zeng
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The aim of this study was to elucidate the correlation between m6A modification and the tumor immune microenvironment (TIME) in prostate cancer (PCa) and to identify the m6A regulation patterns suitable for immune checkpoint inhibitors (ICIs) therapy
Externí odkaz:
https://doaj.org/article/aedff11d5faa4097855f91000dea1b16
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Background Recent studies have focused on the correlation between N6-methyladenosine (m6A) modification and specific tumor-infiltrating immune cells. However, the potential roles of m6A modification in the tumor immune landscape remain elusive.Method
Externí odkaz:
https://doaj.org/article/b9da7f6d89f34aec946d549ffa67cad3
Autor:
Shuo Wang, Wei Su, Chuanfan Zhong, Taowei Yang, Wenbin Chen, Guo Chen, Zezhen Liu, Kaihui Wu, Weibo Zhong, Bingkun Li, Xiangming Mao, Jianming Lu
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Prostate cancer (PCa) is a high morbidity malignancy in males, and biochemical recurrence (BCR) may appear after the surgery. Our study is designed to build up a risk score model using circular RNA sequencing data for PCa. The dataset is from the GEO
Externí odkaz:
https://doaj.org/article/016a50b6cfc8479bbbb31bc93d95377f
Autor:
Fen Wang, Weide Zhong, Cong Wang, Chin-Lee Wu, Wallace L. McKeehan, Peng Huang, Helene Pelicano, Liangcai Zhao, Hongchang Gao, Yun Huang, Li Lai, Yuepeng Ke, Pan You, Zhiduan Cai, Shaoyou Liu, Zezhen Liu, Guo Chen, Junchen Liu
Primer sequences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e3e722c833e4afdc4d7314e199980de
https://doi.org/10.1158/0008-5472.22419833.v1
https://doi.org/10.1158/0008-5472.22419833.v1
Autor:
Fen Wang, Weide Zhong, Cong Wang, Chin-Lee Wu, Wallace L. McKeehan, Peng Huang, Helene Pelicano, Liangcai Zhao, Hongchang Gao, Yun Huang, Li Lai, Yuepeng Ke, Pan You, Zhiduan Cai, Shaoyou Liu, Zezhen Liu, Guo Chen, Junchen Liu
This file containing all the supplemental data supporting the statements indicated in the manuscripts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27c1646208eb4193608eb480726509e0
https://doi.org/10.1158/0008-5472.22419839.v1
https://doi.org/10.1158/0008-5472.22419839.v1
Autor:
Fen Wang, Weide Zhong, Cong Wang, Chin-Lee Wu, Wallace L. McKeehan, Peng Huang, Helene Pelicano, Liangcai Zhao, Hongchang Gao, Yun Huang, Li Lai, Yuepeng Ke, Pan You, Zhiduan Cai, Shaoyou Liu, Zezhen Liu, Guo Chen, Junchen Liu
The acquisition of ectopic fibroblast growthfactor receptor 1 (FGFR1) expression is well documented in prostate cancer progression. How it contributes to prostate cancer progression is not fully understood, although it is known to confer a growth adv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c33075f757fa529cc6ca9cc6dd0ca74
https://doi.org/10.1158/0008-5472.c.6510485
https://doi.org/10.1158/0008-5472.c.6510485
Autor:
Daojun Lv, Yuehan Li, Bin Wang, Xiao Tan, Wei-de Zhong, Zezhen Liu, Weibo Zhong, Yaguang Zou, Kaihui Wu, Fangpeng Shu, Yanfei Chen, Xiangming Mao, Shuo Wang, Jianming Lu, Zhenyu Jia, Taowei Yang, Junqi Luo, Chuanfan Zhong
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 26, Iss, Pp 927-944 (2021)
The circRNAs, a new subclass of non-coding RNAs that are catalyzed by RNA-binding proteins (RBPs), have been reported to be associated with the progression of multiple types of cancer. We previously discovered that heterogeneous nuclear ribonucleopro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eff502973a56801fb15887fe1bafa53
http://www.sciencedirect.com/science/article/pii/S2162253121002493
http://www.sciencedirect.com/science/article/pii/S2162253121002493